These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8742809)

  • 21. Neurobiological mechanisms underlying the acquisition and expression of incentive motivation by cocaine-associated stimuli: relationship to craving.
    Pert A
    NIDA Res Monogr; 1994; 145():163-90. PubMed ID: 8742813
    [No Abstract]   [Full Text] [Related]  

  • 22. Behavioral strategies for the evaluation of new pharmacotherapies for drug abuse treatment.
    Mello NK
    NIDA Res Monogr; 1992; 119():150-4. PubMed ID: 1435971
    [No Abstract]   [Full Text] [Related]  

  • 23. Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of cocaine/heroin combinations (Speedball) in rats.
    Hemby SE; Co C; Dworkin SI; Smith JE
    J Pharmacol Exp Ther; 1999 Jan; 288(1):274-80. PubMed ID: 9862781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
    Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
    J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and research perspectives on cocaine abuse: the pharmacotherapy of cocaine abuse.
    Kosten TR
    NIDA Res Monogr; 1993; 135():48-56. PubMed ID: 8289903
    [No Abstract]   [Full Text] [Related]  

  • 26. A method for analyzing strain differences in acquisition of IV cocaine self-administration in mice.
    Vargas-Irwin C; van den Oord EJ; Beardsley PM; Robles JR
    Behav Genet; 2006 Jul; 36(4):525-35. PubMed ID: 16586151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development.
    Platt DM; Rowlett JK; Spealman RD
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):265-82. PubMed ID: 12373428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes.
    Carroll FI; Pawlush N; Kuhar MJ; Pollard GT; Howard JL
    J Med Chem; 2004 Jan; 47(2):296-302. PubMed ID: 14711303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroadaptive changes in the rat brain GABA(B) receptors after withdrawal from cocaine self-administration.
    Frankowska M; Wydra K; Faron-Górecka A; Zaniewska M; Kuśmider M; Dziedzicka-Wasylewska M; Filip M
    Eur J Pharmacol; 2008 Dec; 599(1-3):58-64. PubMed ID: 18848829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitization to the reinforcing effects of cocaine following binge-abstinent self-administration.
    Morgan D; Roberts DC
    Neurosci Biobehav Rev; 2004 Jan; 27(8):803-12. PubMed ID: 15019429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methodologic recommendations for cocaine abuse clinical trials: a clinician-researcher's perspective.
    Nunes EV
    NIDA Res Monogr; 1997; 175():73-95. PubMed ID: 9467793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critique of drug self-administration as a method for predicting abuse potential of drugs.
    Iwamoto E; Martin W
    NIDA Res Monogr; 1988; 81():457-65. PubMed ID: 3136384
    [No Abstract]   [Full Text] [Related]  

  • 33. Commonalities and differences among reinforcers.
    Johanson CE
    NIDA Res Monogr; 1981 Jul; 37():235-7. PubMed ID: 6798461
    [No Abstract]   [Full Text] [Related]  

  • 34. Animal models of drug self-administration by smoking.
    Wood RW
    NIDA Res Monogr; 1990; 99():159-71. PubMed ID: 2267011
    [No Abstract]   [Full Text] [Related]  

  • 35. Animal models of oral drug self-administration [proceedings].
    McMillan DE
    Psychopharmacol Bull; 1977 Jan; 13(1):38-9. PubMed ID: 13450
    [No Abstract]   [Full Text] [Related]  

  • 36. Nathan B. Eddy Memorial Award Lecture.
    Schuster CR
    NIDA Res Monogr; 1990; 105():6-19. PubMed ID: 1876137
    [No Abstract]   [Full Text] [Related]  

  • 37. Treating drug abuse: beyond bromocriptine.
    Hoffman JR
    J Gen Intern Med; 1993 Jan; 8(1):48-9. PubMed ID: 8419563
    [No Abstract]   [Full Text] [Related]  

  • 38. Potential toxic interactions of cocaine and mazindol.
    Jaffe JH; Witkin JM; Goldberg SR; Katz JL
    Lancet; 1989 Jul; 2(8654):111. PubMed ID: 2567862
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacological approaches to cocaine dependence.
    Kosten TR
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():70A-71A. PubMed ID: 1498999
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical freedom and drug dependence. No rationale for prescribing cocaine to addicts.
    Johns A
    BMJ; 1993 Dec; 307(6918):1565. PubMed ID: 8123150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.